Durgical
EN
Open the app

Giving insulin safely: types by action, pens and syringes, sites, rotation and storage

  • Procedure

Insulin is a high-alert medicine: the nurse checks the glucose, the product and the meal before every injection and rotates the sites.

Updated

What it is

Insulin is given under the skin with a pen or a syringe. Types are grouped by how fast they start and how long they last: rapid-acting and short-acting insulins cover meals; intermediate-acting (NPH, the only cloudy one) and long-acting insulins cover the basal need; premixed insulins combine two types. Insulin is a high-alert medicine: wrong product, wrong amount, a missed dose, the wrong route or poor monitoring can cause severe harm. This page covers the checks that are specific to insulin; the general subcutaneous technique is on the subcutaneous injection page. The amount and the timing always come from the order and the institutional protocol.

Indications

  • Ordered subcutaneous insulin: basal, prandial (with meals) and correction doses, as the order specifies.
  • Rapid-acting: starts within minutes and is given just before or right after a meal; short-acting (regular): given about half an hour before the meal.
  • Intermediate-acting (NPH): cloudy suspension, once or twice a day; long-acting: no pronounced peak, usually once a day.
  • Premixed insulins (intermediate plus rapid or short-acting) are given before meals and are not mixed with other insulins.

Contraindications and precautions

  • Do not give a dose if the patient has hypoglycaemia or symptoms of one: treat it with the protocol and tell the doctor.
  • If the patient cannot eat, is fasting or has vomited, confirm the order before a prandial dose.
  • Insulin shifts potassium into the cells: check potassium in patients at risk, for example those on diuretics.
  • Independent double check when the institution requires it; never give insulin IM by mistake.
  • Pens and vials are labelled for one patient; a vial is always entered with a new needle and syringe.

Equipment

  • The order and the medication record; the barcode scanner if available.
  • The patient's labelled pen with a new pen needle, or the vial and an insulin syringe.
  • Glucose meter or the most recent glucose result; gloves and alcohol swabs.
  • Sharps container at the point of use.

Step by step (and why)

  1. Verify the order and the rights, and identify the patient with two identifiers (and barcode): look-alike products and names cause errors.
  2. Check the current glucose and ask about symptoms of a low: never give insulin without a current value.
  3. Confirm the meal is there and the patient can eat before a prandial dose: insulin without food causes hypoglycaemia.
  4. Check product, patient label, open date and appearance; gently roll or invert NPH: an uneven suspension changes the dose.
  5. If mixing in a syringe, draw the clear insulin first, then NPH; do an independent double check if required.
  6. Tell the patient the glucose value, the insulin and its action: the patient is a last safety check and learns the regimen.
  7. Choose a site in the abdomen, thigh or upper arm and move away from the last spot within the same region: rotation prevents lipodystrophy.
  8. Inject under the skin; with a pen, count to at least five before withdrawing the needle: the full dose is delivered.
  9. Discard the needle at once in the sharps container at the point of use: this prevents needlestick injuries.
  10. Record dose, site and time, and watch for a low around the expected peak of that insulin.

Complications

  • Hypoglycaemia: the most frequent and dangerous complication; risk is higher in older adults and with beta-blockers, which can hide the signs.
  • Lipodystrophy (lumps or dents) at overused sites, which also makes absorption unpredictable.
  • Hypokalaemia, especially with IV insulin.
  • Bloodborne infection if a pen or a needle is shared; errors from wrong product, omitted dose or wrong route.

Next step: when to call for help

  • Call at once if the glucose is below the protocol threshold or the patient has signs of a low after insulin.
  • Report before giving the dose if the patient cannot eat, is fasting, is vomiting or the glucose is very high.
  • Report any insulin error (wrong product, amount, patient or route) immediately and follow the adverse-event process.
  • Storage: unopened vials and pens are refrigerated until expiry; once opened, label the date and discard after the period set for that product.

Test yourself

Think of the answer, then tap the question to see it.

Which insulin is cloudy and must be gently rolled before use?

Intermediate-acting NPH insulin. The others should be clear and colourless; any insulin with particles or an unusual colour is not used.

When mixing a rapid-acting insulin with NPH in one syringe, which one is drawn first?

The clear insulin (rapid or short-acting) first, then the cloudy NPH. Premixed insulins and some other products are not mixed.

Why must an insulin pen never be shared between patients, even with a new needle?

Blood can flow back into the cartridge after an injection, so a shared pen can transmit bloodborne infections. One pen is for one patient.

What does the nurse check right before a prandial insulin dose?

The current glucose, symptoms of a low, that the meal has arrived and the patient can eat, the order, the product and the patient's identity.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of nursing

Educational content for students; it does not replace your institution's protocols, supervised clinical training or a prescriber's order. Dose-calculation examples use made-up numbers: they are educational, not a clinical order.

Sources: Nursing Pharmacology, 9.4: Antidiabetics (Open RN, Wisconsin Technical College System (CC BY 4.0), LibreTexts, 2023); Considerations for Blood Glucose Monitoring and Insulin Administration (Centers for Disease Control and Prevention (CDC), 2024); 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2025 (American Diabetes Association Professional Practice Committee, Diabetes Care (PMC), 2025).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.